Comparison Overview

Biotron Laboratories, Inc. (now Actylis)

VS

Brenntag

Biotron Laboratories, Inc. (now Actylis)

750 North 120 West, Centerville, 84014, US
Last Update: 2026-04-03
View Profile
Between 750 and 799
https://www.actylis.com

Actylis was created from the merger of eight experienced specialty manufacturing companies and three sourcing firms, integrated into a single entity. Actylis is a leading manufacturer and supplier of critical raw materials and performance ingredients serving the Life Sciences, Specialty Chemicals, and AgriScience industries. Actylis' Nutrition division specializes in manufacturing mineral amino acid chelates and complexes. Our goal is to provide our corporate customers top-tier service and continual product improvement resulting in premium materials. To accomplish these goals, we rely on a depth of experience, a rigorous approach to product quality and emphasize both scientific validation and integrity.

NAICS: 325
NAICS Definition: Chemical Manufacturing
Employees: 18
Subsidiaries: 1
12-month incidents
0
Known data breaches
0
Attack type number
0
View Profile

Brenntag

Messeallee 11, Essen , 45131, DE
Last Update: 2026-04-01
Between 700 and 749
https://www.brenntag.com/corporate/en/

Brenntag is the global market leader in chemicals and ingredients distribution and holds a central role in connecting customers and suppliers of the chemical industry. Headquartered in Essen, Germany, we have more than 18,100 employees worldwide and operate a network of around 600 sites in more than 70 countries. In 2024, the company generated sales of €16.2 billion. The two global divisions, Brenntag Essentials and Brenntag Specialties, provide a diversified and broad portfolio of industrial and specialty chemicals and ingredients as well as tailor-made application, marketing and supply chain solutions, technical and formulation support, comprehensive regulatory know-how and digital solutions for a wide range of industries. Brenntag pursues an ambitious sustainability agenda and is committed to sustainable solutions in its own sector and the industries served. Brenntag SE shares have been listed on the Frankfurt Stock Exchange since 2010 and have been part of the DAX since September 2021. In addition, the Brenntag SE shares are listed in the DAX 30 ESG and DAX ESG Target.

NAICS: 325
NAICS Definition: Chemical Manufacturing
Employees: 11,986
Subsidiaries: 19
12-month incidents
0
Known data breaches
1
Attack type number
3

Compliance Badges Comparison

Security & Compliance Standards Overview

https://images.rankiteo.com/companyimages/biotron-laboratories-inc..jpeg
Biotron Laboratories, Inc. (now Actylis)
—
ISO 27001
ISO 27001 certification not verified
Not verified
—
SOC2 Type 1
SOC2 Type 1 certification not verified
Not verified
—
SOC2 Type 2
SOC2 Type 2 certification not verified
Not verified
—
GDPR
GDPR certification not verified
Not verified
—
PCI DSS
PCI DSS certification not verified
Not verified
—
HIPAA
HIPAA certification not verified
Not verified
https://images.rankiteo.com/companyimages/brenntag.jpeg
Brenntag
—
ISO 27001
ISO 27001 certification not verified
Not verified
—
SOC2 Type 1
SOC2 Type 1 certification not verified
Not verified
—
SOC2 Type 2
SOC2 Type 2 certification not verified
Not verified
—
GDPR
GDPR certification not verified
Not verified
—
PCI DSS
PCI DSS certification not verified
Not verified
—
HIPAA
HIPAA certification not verified
Not verified
Compliance Summary
Biotron Laboratories, Inc. (now Actylis)
100%
Compliance Rate
0/4 Standards Verified
Brenntag
0%
Compliance Rate
0/4 Standards Verified

Benchmark & Cyber Underwriting Signals

Incidents vs Chemical Manufacturing Industry Average (This Year)

No incidents recorded for Biotron Laboratories, Inc. (now Actylis) in 2026.

Incidents vs Chemical Manufacturing Industry Average (This Year)

No incidents recorded for Brenntag in 2026.

Incident History — Biotron Laboratories, Inc. (now Actylis) (X = Date, Y = Severity)

Biotron Laboratories, Inc. (now Actylis) cyber incidents detection timeline including parent company and subsidiaries

Incident History — Brenntag (X = Date, Y = Severity)

Brenntag cyber incidents detection timeline including parent company and subsidiaries

Notable Incidents

Last 3 Security & Risk Events by Company

https://images.rankiteo.com/companyimages/biotron-laboratories-inc..jpeg
Biotron Laboratories, Inc. (now Actylis)
Incidents

No Incident

https://images.rankiteo.com/companyimages/brenntag.jpeg
Brenntag
Incidents

Date Detected: 1/2026
Type:Cyber Attack
Attack Vector: Phishing (Voicemail-Themed Lure)
Blog: Blog

Date Detected: 5/2021
Type:Ransomware
Motivation: Financial Gain
Blog: Blog

Date Detected: 4/2021
Type:Breach
Attack Vector: Unauthorized Access (Hacking)
Blog: Blog

FAQ

Biotron Laboratories, Inc. (now Actylis) company demonstrates a stronger AI Cybersecurity Score compared to Brenntag company, reflecting its advanced cybersecurity posture governance and monitoring frameworks.

Brenntag company has historically faced a number of disclosed cyber incidents, whereas Biotron Laboratories, Inc. (now Actylis) company has not reported any.

In the current year, Brenntag company has reported more cyber incidents than Biotron Laboratories, Inc. (now Actylis) company.

Brenntag company has confirmed experiencing a ransomware attack, while Biotron Laboratories, Inc. (now Actylis) company has not reported such incidents publicly.

Brenntag company has disclosed at least one data breach, while Biotron Laboratories, Inc. (now Actylis) company has not reported such incidents publicly.

Brenntag company has reported targeted cyberattacks, while Biotron Laboratories, Inc. (now Actylis) company has not reported such incidents publicly.

Neither Biotron Laboratories, Inc. (now Actylis) company nor Brenntag company has reported experiencing or disclosing vulnerabilities publicly.

Neither Biotron Laboratories, Inc. (now Actylis) nor Brenntag holds any compliance certifications.

Neither company holds any compliance certifications.

Brenntag company has more subsidiaries worldwide compared to Biotron Laboratories, Inc. (now Actylis) company.

Brenntag company employs more people globally than Biotron Laboratories, Inc. (now Actylis) company, reflecting its scale as a Chemical Manufacturing.

Neither Biotron Laboratories, Inc. (now Actylis) nor Brenntag holds SOC 2 Type 1 certification.

Neither Biotron Laboratories, Inc. (now Actylis) nor Brenntag holds SOC 2 Type 2 certification.

Neither Biotron Laboratories, Inc. (now Actylis) nor Brenntag holds ISO 27001 certification.

Neither Biotron Laboratories, Inc. (now Actylis) nor Brenntag holds PCI DSS certification.

Neither Biotron Laboratories, Inc. (now Actylis) nor Brenntag holds HIPAA certification.

Neither Biotron Laboratories, Inc. (now Actylis) nor Brenntag holds GDPR certification.

Latest Global CVEs (Not Company-Specific)

Description

Hirschmann EagleSDV version 05.4.01 prior to 05.4.02 contains a denial-of-service vulnerability that causes the device to crash during session establishment when using TLS 1.0 or TLS 1.1. Attackers can trigger a crash by initiating TLS connections with these protocol versions to disrupt service availability.

Published
Date
2026-04-02
Updated
Date
2026-04-02
Risk Information
cvss3
Base: 7.5
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:N/I:N/A:H
cvss4
Base: 8.7
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:N/VI:N/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
References
Description

The stored API keys in temporary browser client is not marked as protected allowing for JavScript console or other errors to allow for extraction of the encryption credentials.

Published
Date
2026-04-02
Updated
Date
2026-04-02
References
Description

XSS vulnerability in cveInterface.js allows for inject HTML to be passed to display, as cveInterface trusts input from CVE API services

Published
Date
2026-04-02
Updated
Date
2026-04-02
References
Description

Multiple reflected cross-site scripting (XSS) vulnerabilities in the login.php endpoint of Interzen Consulting S.r.l ZenShare Suite v17.0 allows attackers to execute arbitrary Javascript in the context of the user's browser via a crafted URL injected into the codice_azienda and red_url parameters.

Published
Date
2026-04-02
Updated
Date
2026-04-02
References
Description

A reflected cross-site scripting (XSS) vulnerability in the login_newpwd.php endpoint of Interzen Consulting S.r.l ZenShare Suite v17.0 allows attackers to execute arbitrary Javascript in the context of the user's browser via a crafted URL injected into the codice_azienda parameter.

Published
Date
2026-04-02
Updated
Date
2026-04-02
References